JP Morgan Chase’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810M Buy
1,775,810
+1,345,421
+313% +$357M 0.04% 322
2026
Q1
$43.2M Sell
430,389
-273,080
-39% -$38.9M ﹤0.01% 1487
2025
Q4
$117M Sell
703,469
-100,043
-12% -$16.7M 0.01% 876
2025
Q3
$157M Sell
803,512
-142,580
-15% -$23.4M 0.01% 796
2025
Q2
$85.5M Buy
946,092
+8,870
+0.9% +$701K 0.01% 1007
2025
Q1
$55.9M Sell
937,222
-1,423,245
-60% -$132M ﹤0.01% 1252
2024
Q4
$313M Buy
2,360,467
+792,153
+51% +$74.3M 0.02% 512
2024
Q3
$82.2M Buy
1,568,314
+147,569
+10% +$6.93M 0.01% 1050
2024
Q2
$86M Buy
1,420,745
+820,105
+137% +$56.9M 0.01% 979
2024
Q1
$44.6M Buy
+600,640
New +$44.5M ﹤0.01% 1357

Other funds holding ALAB

JP Morgan Chase's ALAB Position: Q2 2026 in Review

JP Morgan Chase increased its Astera Labs (ALAB) stake by 313% in Q2 2026, buying an estimated $357M and bringing the position to 1,775,810 shares worth $810M. The position accounts for 0.04% of the portfolio, ranked #322.

JP Morgan Chase first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • JP Morgan Chase held 1,775,810 shares of Astera Labs worth $810M as of Q2 2026.
  • JP Morgan Chase bought 1,345,421 Astera Labs shares in Q2 2026, an estimated $357M.
  • Astera Labs made up 0.04% of JP Morgan Chase's portfolio in Q2 2026, its #322 holding.
  • JP Morgan Chase first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.